Related Articles
Pursue Remission
Disease remission should be the goal for all rheumatologists treating childhood arthritis
A&R Abstracts: Methotrexate
For further reading
Reading Rheum
Handpicked Reviews of Contemporary Literature
Case Report: RA Patient Suffers Methotrexate-Induced Cutaneous Lesions
Methotrexate (MTX) remains the predominant medication used by rheumatologists to treat rheumatoid arthritis (RA). Doses of 7.5–25 mg per week with daily folic acid are generally prescribed. Despite its common use, MTX must be prescribed cautiously given the potential adverse effects when taken incorrectly or without folic acid supplementation. Cases of MTX-induced cutaneous ulceration have…